Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Bernstein

Showing results (391-400 of 606) with videos related to

Pageof 61
Sort By:
Allergy|October 7, 2024
Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension studyAvner Reshef, Connie Hsu, Constance H Katelaris, et al.
Pediatric Neurology|November 7, 2018
Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid SyndromeSiddharth Srivastava, Benoit Scherrer, Anna K Prohl, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 26, 2019
Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized StudyWilliam R Lumry, Inmaculada Martinez-Saguer, William H Yang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 8, 2024
Allergic Diseases and Mental HealthAlexandra E Conway, Marylee Verdi, Navya Kartha, et al.
Allergy & Rhinology (Providence, R.I.)|April 7, 2017
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedemaTimothy Craig, Ralph Shapiro, Arthur Vegh, et al.
American Journal of Human Genetics|February 4, 2017
The Undiagnosed Diseases Network: Accelerating Discovery about Health and DiseaseRachel B Ramoni, John J Mulvihill, David R Adams, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2009
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacksTimothy J Craig, Robyn J Levy, Richard L Wasserman, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
Exome sequencing identifies de novo pathogenic variants in <i>FBN1</i> and <i>TRPS1</i> in a patient with a complex connective tissue phenotypeDiane B Zastrow, Patricia A Zornio, Annika Dries, et al.
Journal of Clinical Immunology|May 9, 2023
Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion RegimensSudhir Gupta, James DeAngelo, Isaac Melamed, et al.
The Journal of Allergy and Clinical Immunology. Global|March 17, 2025
Randomized trial of ultraviolet irradiation units installed in homes of children and adolescents with asthmaJonathan A Bernstein, Anand Seth, Marepalli Rao, et al.
Pageof 61

Showing results (391-400 of 606) with videos related to

Sort By:
Pageof 61
Allergy|October 7, 2024
Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension studyAvner Reshef, Connie Hsu, Constance H Katelaris, et al.
Pediatric Neurology|November 7, 2018
Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid SyndromeSiddharth Srivastava, Benoit Scherrer, Anna K Prohl, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 26, 2019
Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized StudyWilliam R Lumry, Inmaculada Martinez-Saguer, William H Yang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 8, 2024
Allergic Diseases and Mental HealthAlexandra E Conway, Marylee Verdi, Navya Kartha, et al.
Allergy & Rhinology (Providence, R.I.)|April 7, 2017
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedemaTimothy Craig, Ralph Shapiro, Arthur Vegh, et al.
American Journal of Human Genetics|February 4, 2017
The Undiagnosed Diseases Network: Accelerating Discovery about Health and DiseaseRachel B Ramoni, John J Mulvihill, David R Adams, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2009
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacksTimothy J Craig, Robyn J Levy, Richard L Wasserman, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
Exome sequencing identifies de novo pathogenic variants in <i>FBN1</i> and <i>TRPS1</i> in a patient with a complex connective tissue phenotypeDiane B Zastrow, Patricia A Zornio, Annika Dries, et al.
Journal of Clinical Immunology|May 9, 2023
Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion RegimensSudhir Gupta, James DeAngelo, Isaac Melamed, et al.
The Journal of Allergy and Clinical Immunology. Global|March 17, 2025
Randomized trial of ultraviolet irradiation units installed in homes of children and adolescents with asthmaJonathan A Bernstein, Anand Seth, Marepalli Rao, et al.
Pageof 61